ATHIRA PHARMA
Athira Pharma is a clinical-stage drug development company striving to improve human health by advancing bold and innovative therapies with the potential to restore the lives of people impacted by brain disorders. Athira is derived from the word Athir, the energy that reaches everyone. It captures its mission to develop therapies that can reach and positively impact everyone.
ATHIRA PHARMA
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2011-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.athira.com
Total Employee:
51+
Status:
Active
Contact:
(206) 221-8112
Email Addresses:
[email protected]
Total Funding:
233.6 M USD
Technology used in webpage:
SPF Apple Mobile Web Clips Icon Google Universal Analytics Microsoft Exchange Online Office 365 Mail Pound Sterling YouTube Japanese Yen Sectigo SSL Sectigo Domain SSL
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Aestus Partners
Aestus Partners is a business advisory firm in the field of biotechnology and pharmaceuticals.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
MediGene
MediGene is a company that specializes in biotechnology specifically in the treatment of cancer.
PSNResearch
PSNResearch is a Pharmaceutical Manufacturing Company that specializes in biotechnology, pharmaceutical.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
National Institute on Aging
National Institute on Aging investment in Grant - Athira Pharma
Primer Capital
Primer Capital investment in Convertible Note - Athira Pharma
Avidity Partners
Avidity Partners investment in Series B - Athira Pharma
Viking Global Investors
Viking Global Investors investment in Series B - Athira Pharma
Highline Capital Management
Highline Capital Management investment in Series B - Athira Pharma
Franklin Templeton
Franklin Templeton investment in Series B - Athira Pharma
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Series B - Athira Pharma
Richard Kayne
Richard Kayne investment in Series B - Athira Pharma
Suzanne Kayne
Suzanne Kayne investment in Series B - Athira Pharma
Ditch Plains Capital Management LP
Ditch Plains Capital Management LP investment in Series B - Athira Pharma
Key Employee Changes
Official Site Inspections
http://www.athira.com
- Host name: 45.60.98.212
- IP address: 45.60.98.212
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Athira Pharma"
Athira Pharma
Dec 6, 2024 Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects of ATH-1105 in Models of ALS at Motor Neurone Disease Association’s 35th International Symposium on ALS/MND. November 7, 2024. …See details»
Athira Pharma - Wikipedia
Athira Pharma is a late clinical stage American biopharmaceutical company developing small molecules to restore neuronal health and stop the neurodegeneration brought on by diseases such as Alzheimer's disease and Parkinson's disease. The company's lead candidate, ATH-1017, is in human studies for Alzheimer's disease as of 2021. See details»
Athira Pharma - Crunchbase Company Profile & Funding
Athira Pharma is a clinical-stage drug development company striving to improve human health by advancing bold and innovative therapies with the potential to restore the lives of people impacted by brain disorders. Athira is derived from …See details»
Corporate Presentation - Athira Pharma
Information presented in this press release is solely the responsibility of Athira and does not necessarily represent the official views of the National Institutes of Health. This presentation …See details»
Athira Pharma - businessabc.net
Nov 24, 2024 Athira Pharma was known as M3 Biotechnology until it underwent a name change on April 11, 2019. Mission Our mission is to provide our customers and partners with a …See details»
Restoring Lives by Advancing Bold Therapies - athira.com
Athira and does not necessarily represent the official views of the National Institutes of Health. This presentation concerns drug candidates that are under clinical investigation and which …See details»
Athira Pharma - Overview, News & Similar companies - ZoomInfo
Apr 15, 2024 Who is Athira Pharma. Athira Pharma Inc., headquartered in the Seattle area, is a late clinical-stage biopharmaceutical company focused on developing small molecules to …See details»
Athira Pharma - Craft
Oct 29, 2024 Athira Pharma a drug development company intended to develop therapies for neurodegenerative diseases. The company develops drugs focused on turning brain …See details»
Athira Files Investor Presentation Highlighting Successful …
Apr 26, 2022 Athira has a strong management team led by CEO Mark Litton, Ph.D., M.B.A. Litton has significant executive leadership, clinical development, commercialization, …See details»
Athira Urges Shareholders to Support its Director Nominees at …
Athira is well capitalized and advantageously positioned to execute key objectives with cash on hand to fund the organization through multiple upcoming clinical milestones, including receipt …See details»
Athira Pharma Reports First Quarter 2024 Financial Results and …
Athira Pharma, Inc. Topline data from Phase 2/3 LIFT-AD clinical trial of fosgonimeton as a potential treatment for mild-to-moderate Alzheimer’s disease expected in second half of 2024 .See details»
Athira Pharma Reports Third Quarter 2024 Financial Results and …
Nov 7, 2024 Athira is conducting a first-in-human Phase 1 (NCT 06432647) double-blind, placebo-controlled trial that is enrolling up to 80 healthy volunteers to evaluate single and …See details»
Athira Pharma Highlights Strong Execution of Strategy and …
BOTHELL, Wash., March 30, 2022 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small …See details»
Therapeutic Focus - Athira Pharma
At Athira, We Are Focused on Improving Neuronal Health by Promoting Natural Repair Systems. ... Sperling, et al., 2011; World Health Organization) Parkinson’s Disease, PD Dementia and …See details»
Athira exploring strategic alternatives after Alzheimer’s failure
Nov 8, 2024 Athira had nearly $69 million in cash, cash equivalents and investments at the end of September. Dive Insight: Founded in 2011 under the name M3 Biotechnology, Athira has …See details»
What is Athira? Company Culture, Mission, Values | Glassdoor
See what employees say it's like to work at Athira. Salaries, reviews, and more - all posted by employees working at Athira.See details»
Leading Independent Proxy Advisory Firm ISS Recommends that …
BOTHELL, Wash., May 04, 2022 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to …See details»
Athira - Name Meaning and Origin
The name "Athira" is of Indian origin and is commonly used as a feminine given name. It is derived from the Sanskrit word "athira" which means "quick" or "nimble." Individuals with this …See details»
Athira Pharma Announces Publication of Phase 1 Results for …
Announces fosgonimeton as World Health Organization’s recommended international nonproprietary name for ATH-1017. BOTHELL, Wash., Feb. 22, 2022 ... Athira may not …See details»